MeSH term
Frequency | Condition_Probility | Female | 18 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Humans | 35 | 0.0 |
Microsatellite Repeats/*genetics | 2 | 0.0 |
Ovarian Neoplasms/*genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 21 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
*Alleles | 3 | 0.0 |
Genetic Markers | 4 | 0.0 |
Loss of Heterozygosity | 2 | 0.0 |
Neoplasm Staging | 4 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Adult | 6 | 0.0 |
Aged | 3 | 0.0 |
*Chromosome Aberrations | 2 | 0.0 |
*Chromosomes, Human, Pair 17 | 14 | 2.0 |
DNA, Neoplasm/analysis | 4 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Male | 8 | 0.0 |
Middle Aged | 5 | 0.0 |
*Nucleoside-Diphosphate Kinase | 4 | 6.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Prognosis | 4 | 0.0 |
Retrospective Studies | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 10 | 0.0 |
Base Sequence | 13 | 0.0 |
Chromosome Mapping | 11 | 0.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
DNA, Complementary/analysis | 2 | 0.0 |
Mice | 7 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
*Monomeric GTP-Binding Proteins | 8 | 17.0 |
Multigene Family | 3 | 0.0 |
Nucleoside-Diphosphate Kinase/*genetics | 2 | 66.0 |
Rats | 3 | 0.0 |
Transcription Factors/*genetics | 5 | 0.0 |
Alleles | 4 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Breast Neoplasms/*genetics/pathology | 3 | 1.0 |
Neoplasm Metastasis | 5 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
*Genes, Tumor Suppressor | 7 | 0.0 |
Neoplasm Metastasis/*genetics | 2 | 3.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
Gene Amplification | 3 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
Nucleoside-Diphosphate Kinase/*analysis | 2 | 100.0 |
Survival Rate | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
Colorectal Neoplasms/*genetics/pathology | 2 | 2.0 |
*Gene Deletion | 2 | 0.0 |
Breast Neoplasms/*genetics | 6 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Lod Score | 3 | 0.0 |
Pedigree | 4 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
*Chromosome Deletion | 3 | 0.0 |
Proto-Oncogene Proteins/genetics | 3 | 0.0 |
Heterozygote | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Receptor, Epidermal Growth Factor/genetics | 2 | 1.0 |
Receptor, erbB-2 | 2 | 1.0 |
Mutation | 2 | 0.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
